Home/DiscGenics/Flagg Flanagan

FF

Flagg Flanagan

Chief Executive Officer & Chairman of the Board

Therapeutic Areas

Degenerative Disc Disease Chronic Low Back Pain Spinal Disorders

DiscGenics Pipeline

Drug	Indication	Phase
IDCT (rebonuputemcel)	Symptomatic, mild to moderate lumbar degenerative disc disease (DDD) in adults	Phase 3

Leadership Team at DiscGenics

Chief Operating & Commercialization Officer, Director

View full DiscGenics profile